1.
Ann Surg Oncol
; 31(11): 7418-7419, 2024 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38735901
2.
Am J Transplant
; 17(1): 292-295, 2017 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27501470
RESUMO
The concern about cancer recurrence has traditionally resulted in delaying kidney transplantation for 2-5 years after a cancer diagnosis in patients who are otherwise eligible for transplant. This period of inactive status to observe the tumor biology can result in significant morbidity and decreased quality of life for patients with end-stage renal disease (ESRD). We reported the novel application of genomic profiling assays in breast cancer to identify low-risk cancers in two patients with ESRD who were able to have the mandatory inactive status eliminated prior to kidney transplantation.